Nanoscale Technologies in Highly Sensitive Diagnosis of Cardiovascular Diseases

Chaohong Shi, Haotian Xie, Yifan Ma, Zhaogang Yang, Jingjing Zhang

Research output: Contribution to journalReview articlepeer-review

17 Scopus citations


Cardiovascular diseases (CVD) are the leading cause of death and morbidity in the world and are a major contributor to healthcare costs. Although enormous progress has been made in diagnosing CVD, there is an urgent need for more efficient early detection and the development of novel diagnostic tools. Currently, CVD diagnosis relies primarily on clinical symptoms based on molecular imaging (MOI) or biomarkers associated with CVDs. However, sensitivity, specificity, and accuracy of the assay are still challenging for early-stage CVDs. Nanomaterial platform has been identified as a promising candidate for improving the practical usage of diagnostic tools because of their unique physicochemical properties. In this review article, we introduced cardiac biomarkers and imaging techniques that are currently used for CVD diagnosis. We presented the applications of various nanotechnologies on diagnosis within cardiac immunoassays (CIAs) and molecular imaging. We also summarized and compared different cardiac immunoassays based on their sensitivities and working ranges of biomarkers.

Original languageEnglish (US)
Article number531
JournalFrontiers in Bioengineering and Biotechnology
StatePublished - Jun 5 2020


  • biomarker
  • cardiovascular disease (CVD)
  • diagnostic
  • molecular imaging
  • nanotechnology

ASJC Scopus subject areas

  • Biotechnology
  • Bioengineering
  • Histology
  • Biomedical Engineering


Dive into the research topics of 'Nanoscale Technologies in Highly Sensitive Diagnosis of Cardiovascular Diseases'. Together they form a unique fingerprint.

Cite this